International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Special Issue 6
Original Research Article
Post-operative Pain and Recovery in Laparoscopic vs Open Inguinal Hernia Repair: A Randomized Clinical Trial
Published
Feb. 28, 2024
Abstract

Background: Inguinal hernia repair is one of the most common surgical procedures worldwide. Despite the increasing use of laparoscopic techniques, debate continues regarding their comparative effectiveness versus open approaches. This study aimed to compare post-operative pain and recovery outcomes between laparoscopic and open inguinal hernia repair. Methods: This prospective, randomized, controlled, single-blinded trial included 180 patients with primary unilateral inguinal hernias randomized to either laparoscopic totally extraperitoneal (TEP) repair (n=90) or open Lichtenstein repair (n=90). Primary outcome was post-operative pain measured using Visual Analog Scale (VAS) at multiple time points. Secondary outcomes included analgesic requirements, hospital stay, recovery times, chronic pain incidence, complications, quality of life, and cost-effectiveness. Results: The laparoscopic group demonstrated significantly lower pain scores at all early post-operative time points (6 hours: 3.8±1.4 vs. 5.2±1.6, p<0.001; 24 hours: 2.5±1.1 vs. 3.8±1.3, p<0.001). Hospital stay was shorter in the laparoscopic group (8.7±3.5 vs. 13.9±5.2 hours, p<0.001), with earlier return to normal activities (median 5 vs. 8 days, p<0.001) and work (median 10 vs. 14 days, p<0.001). Chronic pain at 12 months was less frequent after laparoscopic repair (4.6% vs. 12.8%, p=0.049). Overall complication rates were comparable (13.3% vs. 16.7%, p=0.534). Quality of life was better in the laparoscopic group during early recovery but equalized by 6 months. From a societal perspective, laparoscopic repair was cost-effective despite higher direct costs. Conclusion: Laparoscopic inguinal hernia repair results in less post-operative pain.

Recommended Articles
Loading Image...
Volume-5, Special Issue 6
Citations
1930 Views
435 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved